Skip to main content
. 2025 Apr 11;15:1549646. doi: 10.3389/fonc.2025.1549646

Table 3.

Malignancy risk of Bethesda category III/IV thyroid nodules in different TI-RADS.

Category Benign (n) Malignant (n) Malignancy rate (%) Recommended malignancy rate (%) P-value P for trend2
ACR-TIRADS <0.001 <0.001
3 7 0 0.0 5%
4 22 9 29.0 5%–20%
5 10 32 76.2 >20%
K-TIRADS <0.001 <0.001
3 7 0 0.0 3%–10%
4 24 13 35.1 10%–40%
5 8 28 77.8 >60%
C-TIRADS <0.001 <0.001
3 5 0 0.0 <2%
4A 17 3 15.0 2%–10%
4B 11 8 42.1 10%–50%
4C 6 28 82.4 50%–90%
5 0 2 100 >90%